65,437 trials
Depressive Disorder, Major · Cannabis Abuse
Primary: Days Per Week of Cannabis Use. — 3.88; 3.1 Days of cannabis use per week — p=<0.05
Prostate Cancer
Primary: Time to Progression (TTP) — 111; 138; 113 Days
Diabetes
Primary: HbA1c Change From Baseline Week 0 to Week 56 — -1.2; -1.56 percent change — p=0.0381
Prediabetic State
Primary: Number of Participants Diagnosed With Prediabetes or Normal Glucose, by 2 Measurements (Fasting Glucose Measurement and Glucose Measurement After a 2-hour Oral Glucose…
Choroidal Neovascularization · Age-Related Maculopathy
Primary: Change From Baseline in Central Retinal Thickness as Measured by Optical Coherence Tomography (OCT) at Week 4 — 360.9; -62.0 Microns
Healthy
Primary: The Change in Skin Tightening in the Upper Inner or Outer Arm (as Measured by Millimeters) — 45.17 millimeters
Antidepressant Activity in Healthy Volunteers
Primary: Number of Voxels Showing Greater Activation Following Escitalopram Compared With Citalopram When Happy and Fearful Faces Are Presented in a Rapid Covert Stimulus…
Choroidal Neovascularization · Age-Related Maculopathy
Primary: Injection Free Interval — 34; 29 Days
Myopia
Primary: Comfort Ratings at Baseline — 86; 59; 57; 81 Percentage of Participants
Type 2 Diabetes Mellitus
Primary: Change From Baseline in HbA1c at Week 28. — -1.1; -0.6 percent change — p=0.0007
Obesity
Primary: Percent Weight Loss From Baseline to Week 28 — 1.7; 5.5; 5.1; 8.5 percent weight loss — p=0.0009
Urinary Incontinence
Primary: Mean Residual Urine Volume — 12.4; 9.4 mL
Pectus Excavatum
Primary: Affect on Cardiac Activity — 0 participants
Antimicrobial Effectiveness
Primary: Antimicrobial Efficacy Will be Measured by the Change (+/-) in Bacterial Count on the Skin 10 Minutes After a Single Application of Test Material Relative to the…
Unspecified Adult Solid Tumor, Protocol Specific
Primary: Determine Maximum Tolerated Dose of BPU — 150 milligrams (mg)